Skip to main content
OpenTrials
Completed

NCT Number: NCT00089869

A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia

Study of a medication for the treatment of Schizophrenia in patients who are already taking Abilify, Risperdal, Seroquel, Zyprexa

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Schizophrenia Mental Disorders Schizophrenia Spectrum and Other Psychotic Disorders

Age range

18 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at (1-877-285-4559) or speak with your personal physician.", Cerritos, California, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Must have a clinical diagnosis of Schizophrenia
  • Must be at least 18 years of age and not older than 55 years of age
  • Must have been stable on a dose of Abilify, Risperdal, Seroquel, or Zyprexa for the past 8 weeks
  • Women of childbearing potential must be using a medically accepted means of contraception
  • Must be able to swallow capsules

Exclusion criteria

  • Has serious health problems other than Schizophrenia
  • Takes an antidepressant for depression
  • Takes insulin for diabetes
  • Have a history of alcohol or drug dependence (except for nicotine and caffeine) within the past 6 months

Treatment and study plan

Olanzapine

Drug

Atomoxetine

Drug

Placebo

Drug

Sponsors and collaborators

Lead sponsor

Eli Lilly and Company

Industry

Registry information

Important dates

First posted
Aug 18, 2004
Registry last updated
Jul 20, 2006

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.